Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Surgalign Holdings, Inc. (SRGA)

    Price:

    0.18 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    SRGA
    Name
    Surgalign Holdings, Inc.
    Industry
    Medical - Devices
    Sector
    Healthcare
    Price
    0.183
    Market Cap
    0
    Enterprise value
    6.942M
    Currency
    USD
    Ceo
    Terry M. Rich
    Full Time Employees
    217
    Ipo Date
    2000-08-11
    City
    Deerfield
    Address
    520 Lake Cook Road

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Abiomed, Inc.

    VALUE SCORE:

    0

    Symbol
    ABMD
    Market Cap
    17.181B
    Industry
    Medical - Devices
    Sector
    Healthcare

    2nd position

    PROCEPT BioRobotics Corporation

    VALUE SCORE:

    9

    Symbol
    PRCT
    Market Cap
    2.199B
    Industry
    Medical - Devices
    Sector
    Healthcare

    The best

    Viemed Healthcare, Inc.

    VALUE SCORE:

    11

    Symbol
    VMD
    Market Cap
    266.959M
    Industry
    Medical - Devices
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.022
    P/S
    0
    P/B
    -0.047
    Debt/Equity
    -0.396
    EV/FCF
    0.103
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    -0.074
    Earnings yield
    -45.544
    Debt/assets
    0.145
    FUNDAMENTALS
    Net debt/ebidta
    0.089
    Interest coverage
    -69.810
    Research And Developement To Revenue
    0.192
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.139
    Capex to revenue
    0.089
    Capex to depreciation
    3.324
    Return on tangible assets
    -0.777
    Debt to market cap
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    -0.000
    P/CF
    -0.023
    P/FCF
    0
    RoA %
    -77.738
    RoIC %
    -140.784
    Gross Profit Margin %
    49.144
    Quick Ratio
    1.844
    Current Ratio
    2.682
    Net Profit Margin %
    -66.609
    Net-Net
    -8.967
    FUNDAMENTALS PER SHARE
    FCF per share
    -9.056
    Revenue per share
    12.506
    Net income per share
    -8.330
    Operating cash flow per share
    -7.949
    Free cash flow per share
    -9.056
    Cash per share
    2.486
    Book value per share
    -3.925
    Tangible book value per share
    -3.925
    Shareholders equity per share
    -3.925
    Interest debt per share
    1.709
    TECHNICAL
    52 weeks high
    0.238
    52 weeks low
    0.178
    Current trading session High
    0.238
    Current trading session Low
    0.178
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.899
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -4.783
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.137
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.016

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -152.771
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.635

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    -152.23264999999998%
    P/E
    -0.289
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -11.508
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.049k
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.642
    logo

    Country
    CR
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -13.091
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -20.783

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.002
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.539
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -7.671
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    -2.688405%
    P/E
    -0.000

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.498
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    56.426

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -4.647
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -28.034
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -29.774
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.460
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.125
    DESCRIPTION

    Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

    NEWS
    https://images.financialmodelingprep.com/news/why-is-surgalign-holdings-srga-stock-up-10-today-20230627.jpg
    Why Is Surgalign Holdings (SRGA) Stock Up 10% Today?

    investorplace.com

    2023-06-27 08:14:29

    Surgalign Holdings (NASDAQ: SRGA ) stock is on the rise Tuesday after the company recently received a delisting notice alongside its bankruptcy filing. That delisting notice will result in the company's shares being removed from the Nasdaq Exchange at the start of business on July 3.

    https://images.financialmodelingprep.com/news/why-is-surgalign-holdings-srga-stock-down-23-today-20230626.jpg
    Why Is Surgalign Holdings (SRGA) Stock Down 23% Today?

    investorplace.com

    2023-06-26 08:55:49

    Surgalign Holdings (NASDAQ: SRGA ) stock is taking a beating on Monday after the company revealed a delisting notice from the Nasdaq Exchange. This delisting notice has to do with the company's recent Chapter 11 bankruptcy filing.

    https://images.financialmodelingprep.com/news/why-is-surgalign-srga-stock-down-55-today-20230620.jpg
    Why Is Surgalign (SRGA) Stock Down 55% Today?

    investorplace.com

    2023-06-20 08:45:19

    Surgalign (NASDAQ: SRGA ) stock is taking a beating on Tuesday after the spine solutions company filed for Chapter 11 bankruptcy. As a result of this filing and plans to cut costs, several changes are coming to Surgalign.

    https://images.financialmodelingprep.com/news/surgalign-srga-upgraded-to-buy-what-does-it-mean-20230605.jpg
    Surgalign (SRGA) Upgraded to Buy: What Does It Mean for the Stock?

    zacks.com

    2023-06-05 13:11:16

    Surgalign (SRGA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    https://images.financialmodelingprep.com/news/surgalign-holdings-inc-srga-q1-2023-earnings-call-transcript-20230511.jpg
    Surgalign Holdings, Inc. (SRGA) Q1 2023 Earnings Call Transcript

    seekingalpha.com

    2023-05-11 19:49:10

    Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants David Lyle - Chief Financial Officer Terry Rich - President and Chief Executive Officer Chris Thunander - Chief Accounting Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Operator Good day, ladies and gentlemen, and welcome to Surgalign Holdings 2023 First Quarter Results Conference Call and Webcast.

    https://images.financialmodelingprep.com/news/surgalign-holdings-srga-reports-q1-loss-tops-revenue-estimates-20230511.jpg
    Surgalign Holdings (SRGA) Reports Q1 Loss, Tops Revenue Estimates

    zacks.com

    2023-05-11 19:02:40

    Surgalign Holdings (SRGA) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $3.95. This compares to loss of $2.10 per share a year ago.

    https://images.financialmodelingprep.com/news/surgalign-schedules-first-quarter-2023-earnings-release-for-may-20230504.jpg
    Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023

    globenewswire.com

    2023-05-04 08:30:00

    DEERFIELD, Ill., May 04, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its first quarter 2023 after the close of trading on May 11, 2023.

    https://images.financialmodelingprep.com/news/surgalign-holdings-inc-srga-q4-2022-earnings-call-transcript-20230330.jpg
    Surgalign Holdings, Inc. (SRGA) Q4 2022 Earnings Call Transcript

    seekingalpha.com

    2023-03-30 18:30:17

    Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants David Lyle - Chief Financial Officer Terry Rich - President and Chief Executive Officer Conference Call Participants Matt Hewitt - Craig-Hallum Operator Greetings, and welcome to the Surgalign Holdings 2022 Fourth Quarter and Year-End Conference Call. At this time, all participants are in a listen-only mode.

    https://images.financialmodelingprep.com/news/surgalign-schedules-fourth-quarter-and-full-year-2022earnings-release-20230321.jpg
    Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023

    globenewswire.com

    2023-03-21 08:30:00

    DEERFIELD, Ill., March 21, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its fourth quarter and full year 2022 after the close of trading on March 30, 2023.

    https://images.financialmodelingprep.com/news/surgalign-holdings-inc-srga-q3-2022-earnings-call-transcript-20221102.jpg
    Surgalign Holdings, Inc. (SRGA) Q3 2022 Earnings Call Transcript

    seekingalpha.com

    2022-11-02 21:20:26

    Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Terry Rich - Chief Executive Officer David Lyle - Chief Financial Officer Chris Thunander - Chief Accounting Officer Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group Operator Greetings, and welcome to the Surgalign Holdings 2022 Third Quarter Earnings Call. It is now my pleasure to introduce your host, David Lyle.

    https://images.financialmodelingprep.com/news/surgalign-schedules-third-quarter-2022-earnings-release-for-november-20221025.jpg
    Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022

    globenewswire.com

    2022-10-25 08:30:00

    DEERFIELD, Ill., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its third quarter ended September 30, 2022 after the close of trading on November 2, 2022.

    https://images.financialmodelingprep.com/news/surgalign-holdings-inc-srga-ceo-terry-rich-on-q2-20220809.jpg
    Surgalign Holdings, Inc. (SRGA) CEO Terry Rich on Q2 2022 Results - Earnings Call Transcript

    seekingalpha.com

    2022-08-09 22:29:12

    Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q2 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants David Lyle - Chief Financial Officer Terry Rich - President and Chief Executive Officer Chris Thunander - Chief Accounting Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Operator Good day ladies and gentlemen and welcome to the Surgalign Holdings, Incorporated Second Quarter 2022 Results Conference Call. All lines have been placed in a listen only mode and the floor will be open for your questions and comments following the presentation.

    https://images.financialmodelingprep.com/news/heres-why-surgalign-holdings-shares-are-falling-today-20220516.jpg
    Here's Why Surgalign Holdings Shares Are Falling Today

    benzinga.com

    2022-05-16 12:10:08

    Surgalign Holdings Inc (NASDAQ: SRGA) shares are trading lower by 19.73% at $0.15 after the company announced a 1-for-30 reverse stock split. The 1-for-30 reverse stock split will take effect at the opening of trading on the Nasdaq Global Select Market on Tuesday.

    https://images.financialmodelingprep.com/news/surgalign-holdings-srga-ceo-terry-rich-on-q1-2022-20220510.jpg
    Surgalign Holdings' (SRGA) CEO Terry Rich on Q1 2022 Results - Earnings Call Transcript

    seekingalpha.com

    2022-05-10 20:56:08

    Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants David Lyle – Chief Financial Officer Terry Rich – President and Chief Executive Officer Chris Thunander – Chief Accounting Officer Conference Call Participants Brooks O'Neil – Lake Street Capital Matt Hewitt – Craig-Hallum Operator Greetings, and welcome to the Surgalign Holdings, Incorporated First Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode.

    https://images.financialmodelingprep.com/news/surgalign-holdings-inc-srga-ceo-terry-rich-on-q4-2021-20220315.jpg
    Surgalign Holdings, Inc. (SRGA) CEO Terry Rich on Q4 2021 Results - Earnings Call Transcript

    seekingalpha.com

    2022-03-15 21:13:07

    Surgalign Holdings, Inc. (SRGA) CEO Terry Rich on Q4 2021 Results - Earnings Call Transcript

    https://images.financialmodelingprep.com/news/surgalign-holdings-inc-schedules-fourth-quarter-and-full-year-20220308.jpg
    Surgalign Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release for March 15, 2022

    globenewswire.com

    2022-03-08 16:30:00

    DEERFIELD, Ill., March 08, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced it plans to release financial results from the fourth quarter and full year 2021 after the close of trading on March 15, 2022.